Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the name VB Spine, LLC (“VB Spine”)..

Viscogliosi Brothers, LLC是一家专注于神经肌肉骨骼领域的家族投资机构，今日宣布成功完成了此前宣布的从Stryker（纽约证券交易所代码：SYK）收购其美国脊柱业务的交易。该业务将作为一家独立公司运营，名称为VB Spine, LLC（“VB Spine”）。

VB Spine is advancing toward the completion of its acquisition of Stryker’s international spine businesses, pending satisfaction of legal and regulatory requirements, including all required employee consultations. VB Spine is focused on successfully growing and evolving the spine business and expanding its reach to serve surgeons and patients globally..

VB Spine正朝着完成对Stryker国际脊柱业务的收购迈进，此过程有待满足法律和监管要求，包括所有必需的员工咨询。VB Spine专注于成功发展和推动脊柱业务的转型，并扩大其服务范围以惠及全球的外科医生和患者。

VB Spine is dedicated to bringing physicians and patients comprehensive and advanced technology solutions that are clinically proven to deliver improved patient outcomes through surgeon-driven innovation. With a focus on operational excellence and a patient-first approach, VB Spine aims to address critical needs in spine surgery and deliver meaningful improvements in patients’ lives.

VB Spine致力于为医生和患者提供全面且先进的技术解决方案，这些方案通过外科医生驱动的创新，经过临床验证能够改善患者的治疗效果。VB Spine以运营卓越和患者至上为宗旨，旨在解决脊柱手术中的关键需求，为患者的生活带来有意义的改善。

VB Spine’s value proposition to all stakeholders lies in its comprehensive product portfolio, strong distribution network and deep industry expertise, enabling it to provide specialized solutions that empower surgeons and enhance patient care. VB Spine is led by Marc, John and Anthony Viscogliosi, co-founders of Viscogliosi Brothers, LLC..

VB Spine对所有利益相关者的价值主张在于其全面的产品组合、强大的分销网络和深厚的行业专业知识，使其能够提供专业化的解决方案，助力外科医生并提升患者护理水平。VB Spine由Marc、John和Anthony Viscogliosi领导，他们是Viscogliosi Brothers, LLC的共同创始人。

“We are honored to work alongside such a talented team and are confident that, with its strong commitment to innovation, surgeon collaboration and commercial execution, VB Spine is uniquely positioned to improve patient outcomes and drive transformation in spine surgery,” said Marc, John and Anthony Viscogliosi..

“我们很荣幸能与这样一个才华横溢的团队合作，并相信凭借其对创新、外科医生协作和商业执行的强大承诺，VB Spine 独具优势来改善患者预后并推动脊柱外科手术的变革，”Marc、John 和 Anthony Viscogliosi 表示。

“Viscogliosi Brothers has traditionally been known as a leader in spine technology innovations. With the launch of VB Spine, we are building on our innovation legacy by investing in the people and organization that will drive the next phase of transformation in the spine industry. This transaction represents a major milestone in our dedication to operate a portfolio of innovative and enabling technologies that can improve patient outcomes globally.

“Viscogliosi Brothers 一直以来被认为是脊柱技术创新的领导者。随着 VB Spine 的推出，我们正在通过投资于推动脊柱行业下一阶段转型的人才和组织，继续巩固我们的创新传统。这笔交易标志着我们在致力于运营一系列能够改善全球患者预后的创新和赋能技术方面迈出了重要的里程碑。”

We look forward to welcoming the rest of the Stryker Spine family as we move forward in our growth strategy through completing the additional phases of the acquisition in markets outside the U.S.,” continued Messrs. Viscogliosi..

我们期待着在通过完成美国以外市场的收购的其他阶段来推进我们的增长战略时，欢迎Stryker Spine家族的其他成员加入。" Viscoliosi继续说道。

VB Spine has access to Stryker’s Mako Spine and Copilot. This strategic partnership creates a strong foundation for VB Spine’s continued growth, providing surgeons greater precision and improving patient outcomes.

VB Spine 可使用 Stryker 的 Mako Spine 和 Copilot。这一战略性合作伙伴关系为 VB Spine 的持续增长奠定了坚实的基础，为外科医生提供更高的精确度并改善患者预后。

In connection with the transaction, Barings, LLC and Texas Capital Bank are serving as financial partners to Viscogliosi Brothers. Viscogliosi Brothers and Viscogliosi Brothers Watermark Holdings, LLC are equity investors in VB Spine.

与此交易相关，Barings有限责任公司和德克萨斯资本银行正担任Viscogliosi Brothers的财务合作伙伴。Viscogliosi Brothers和Viscogliosi Brothers Watermark Holdings有限责任公司是VB Spine的股权投资者。

Viscogliosi Brothers, LLC was advised in this transaction by McDermott Will & Emery as legal counsel, Piper Sandler as financial advisor, FTI Consulting as carve-out advisors and Deloitte IT and Deloitte Tax as additional carve-out advisory.

Viscogliosi Brothers, LLC 在此交易中获得了 McDermott Will & Emery 担任法律顾问、Piper Sandler 担任财务顾问、FTI Consulting 担任分拆顾问以及德勤 IT 和德勤税务担任额外分拆顾问的建议。

About VB Spine

关于VB Spine

VB Spine, LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. Our globally recognized identity as innovators and stewards of the spine industry reflects our commitment to patient outcomes first. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes.

VB Spine, LLC 是全球最大的私人脊柱公司，也是世界上最大的家族式医疗技术公司之一。我们作为脊柱行业创新者和引领者的全球公认身份，反映了我们始终将患者疗效放在首位的承诺。凭借全面的产品组合以及庞大且不断增长的全球分销网络，VB Spine 提供专门的解决方案，满足脊柱手术中的关键需求并改善患者的治疗效果。

VB Spine is a strategic partner to Stryker with access to Mako Spine and Copilot. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers.

VB Spine 是 Stryker 的战略合作伙伴，拥有对 Mako Spine 和 Copilot 的访问权限。VB Spine 专注于人员、合作关系和运营卓越性，确保医疗专业人员能够获得提供最高标准护理所需的工具和资源。VB Spine 由 Viscogliosi 兄弟拥有并领导。

For more information on VB Spine, please visit www.vbspineco.com..

有关 VB Spine 的更多信息，请访问 www.vbspineco.com。

About Viscogliosi Brothers

关于维斯科利亚兄弟

Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system.

Viscogliosi Brothers, LLC 是一家总部位于纽约市的家族企业，致力于推动神经肌肉骨骼行业的增长与创新。公司成立于1999年，专注于发掘和构建医疗保健领域的突破性创新，旨在满足未被满足的临床需求、改善患者疗效，并提高医疗系统的成本效率。

Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others.

自26年前成立以来，Viscogliosi Brothers已经创立、融资、运营并发展了43家企业，业务和分销遍及80多个国家。这些企业通过尖端的医疗创新为数百万患者带来了积极影响。该公司通过其多个业务推动了脊柱行业的转型，具体包括：Spine Solutions、Spine Next、Paradigm Spine、Simplify Medical、Centinel Spine、Companion Spine、Spine BioPharma和Woven Orthopedic Technologies等。

For more information, visit www.vbllc.com..

欲了解更多信息，请访问 www.vbllc.com。

About Viscogliosi Brothers Watermark

关于维斯科利亚兄弟水印

Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities.

维斯科利亚兄弟水印有限责任公司是一家总部位于纽约市的控股公司，专注于投资医疗技术领域的创新。公司成立于2022年，致力于为其股东创造替代财富，同时提升人类的福祉。凭借以投资组合为导向的授权和战略专长，VBW通过融资和制造能力支持其投资实体。

For more information, visit www.vbwholdings.com..

欲了解更多信息，请访问 www.vbwholdings.com。

About Barings

关于巴林银行

Barings is a $421+ billion* global asset management firm that partners with institutional, insurance, and intermediary clients, and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual, seeks to deliver excess returns by leveraging its global scale and capabilities across public and private markets in fixed income, real assets and capital solutions.

贝莱德是一家管理资产超过4210亿美元的全球资产管理公司，与机构、保险和中介机构客户合作，并通过灵活的融资解决方案支持领先的企业。作为万通保险的子公司，该公司旨在通过其在固定收益、实物资产和资本解决方案领域中跨公共和私人市场的全球规模和能力，实现超额回报。

For more information, visit www.barings.com.

欲了解更多信息，请访问 www.barings.com。

*Assets under management as of December 31, 2024

*截至2024年12月31日的资产管理规模

About Texas Capital

关于德克萨斯资本

Texas Capital Bancshares, Inc., a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank (“TCB”). Texas Capital is the collective brand name for TCB and its separate, non-bank affiliates and wholly-owned subsidiaries. Texas Capital is a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers.

德克萨斯资本银行股份有限公司（Texas Capital Bancshares, Inc.）是罗素2000®指数和标普中型股400®指数的成员，也是德克萨斯资本银行（“TCB”）的母公司。德克萨斯资本是TCB及其独立的非银行附属公司和全资子公司共同使用的品牌名称。德克萨斯资本是一家提供全方位服务的金融服务公司，为各类企业、企业家和个人客户提供定制化的解决方案。

Founded in 1998, the institution is headquartered in Dallas with offices in Austin, Houston, San Antonio and Fort Worth, and has built a network of clients across the country. With the ability to service clients through their entire lifecycles, Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.

成立于 1998 年，总部位于达拉斯，在奥斯汀、休斯顿、圣安东尼奥和沃思堡设有办事处，并且已经在全国建立了客户网络。德克萨斯资本银行具备为客户提供整个生命周期服务的能力，建立了商业银行、零售银行、投资银行和财富管理能力。

All services are subject to applicable laws, regulations, and service terms. Deposit and lending products and services are offered by TCB. For deposit products, member FDIC. For more information, please visit www.texascapital.com..

所有服务均受适用的法律法规和服务条款约束。存款和贷款产品及服务由TCB提供。对于存款产品，FDIC成员。欲了解更多信息，请访问www.texascapital.com。

About Stryker

关于Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.

史赛克是医疗技术领域的全球领导者，与我们的客户一起，我们致力于改善医疗服务。我们在外科、神经技术和骨科领域提供创新的产品和服务，有助于改善患者和医疗效果。与世界各地的客户携手，我们每年影响超过1.5亿名患者。

More information is available at www.stryker.com..

更多信息请访问 www.stryker.com。

Media Contact

媒体联系人

[email protected]

[email protected]

Source: globenewswire.com

来源：globenewswire.com